Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rashmi R Shah

Showing results (1-10 of 57) with videos related to

Pageof 6
Sort By:
British Journal of Clinical Pharmacology|November 4, 2004
Drug development and use in the elderly: search for the right dose and dosing regimen (Parts I and II)Rashmi R Shah
Expert Opinion on Drug Safety|February 16, 2005
Mechanistic basis of adverse drug reactions: the perils of inappropriate dose schedulesRashmi R Shah
Journal of Electrocardiology|January 22, 2005
Drug-induced QT dispersion: does it predict the risk of torsade de pointes?Rashmi R Shah
British Journal of Clinical Pharmacology|September 5, 2002
The significance of QT interval in drug developmentRashmi R Shah
Journal of Clinical Pharmacy and Therapeutics|March 14, 2020
Genotype-guided warfarin therapy: Still of only questionable value two decades onRashmi R Shah
Drug Safety|January 17, 2019
Safety and Tolerability of Histone Deacetylase (HDAC) Inhibitors in OncologyRashmi R Shah
Novartis Foundation Symposium|July 30, 2005
Drug-induced QT interval prolongation--regulatory guidance and perspectives on hERG channel studiesRashmi R Shah
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences|August 13, 2005
Pharmacogenetics in drug regulation: promise, potential and pitfallsRashmi R Shah
Drug Safety|February 10, 2017
Anti-Angiogenic Tyrosine Kinase Inhibitors and Reversible Posterior Leukoencephalopathy Syndrome: Could Hypomagnesaemia Be the Trigger?Rashmi R Shah
Drug Safety - Case Reports|September 22, 2017
Importance of Publishing Adverse Drug Reaction Case Reports: Promoting Public Health and Advancing Pharmacology and TherapeuticsRashmi R Shah
Pageof 6

Showing results (1-10 of 57) with videos related to

Sort By:
Pageof 6
British Journal of Clinical Pharmacology|November 4, 2004
Drug development and use in the elderly: search for the right dose and dosing regimen (Parts I and II)Rashmi R Shah
Expert Opinion on Drug Safety|February 16, 2005
Mechanistic basis of adverse drug reactions: the perils of inappropriate dose schedulesRashmi R Shah
Journal of Electrocardiology|January 22, 2005
Drug-induced QT dispersion: does it predict the risk of torsade de pointes?Rashmi R Shah
British Journal of Clinical Pharmacology|September 5, 2002
The significance of QT interval in drug developmentRashmi R Shah
Journal of Clinical Pharmacy and Therapeutics|March 14, 2020
Genotype-guided warfarin therapy: Still of only questionable value two decades onRashmi R Shah
Drug Safety|January 17, 2019
Safety and Tolerability of Histone Deacetylase (HDAC) Inhibitors in OncologyRashmi R Shah
Novartis Foundation Symposium|July 30, 2005
Drug-induced QT interval prolongation--regulatory guidance and perspectives on hERG channel studiesRashmi R Shah
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences|August 13, 2005
Pharmacogenetics in drug regulation: promise, potential and pitfallsRashmi R Shah
Drug Safety|February 10, 2017
Anti-Angiogenic Tyrosine Kinase Inhibitors and Reversible Posterior Leukoencephalopathy Syndrome: Could Hypomagnesaemia Be the Trigger?Rashmi R Shah
Drug Safety - Case Reports|September 22, 2017
Importance of Publishing Adverse Drug Reaction Case Reports: Promoting Public Health and Advancing Pharmacology and TherapeuticsRashmi R Shah
Pageof 6